| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 07/30/1997 | CN1155418A Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 07/29/1997 | US5651973 Therapeutically effective topical application of ST1435 |
| 07/23/1997 | EP0785212A1 New 19-nor-pregnene derivatives |
| 07/22/1997 | US5650526 Process for the preparation of an oxoetiocholenic acid |
| 06/26/1997 | WO1997022616A1 PROCESS FOR PREPARATION OF 9,11β-EPOXIDE STEROIDS |
| 06/26/1997 | CA2240407A1 Process for preparation of 9,11.beta.-epoxide steroids |
| 06/18/1997 | EP0675897B1 New steroids |
| 06/18/1997 | CN1035182C Prep. of 9-alpha-hydroxy steroids compound |
| 05/28/1997 | EP0775154A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 05/20/1997 | USRE35517 Method, compositions, and compounds for modulating brain excitability |
| 05/14/1997 | CN1034868C Preparing method for 6 alpha, 9 alpha-difluorido-progester-3,20-diones compound |
| 04/23/1997 | EP0600873B1 Therapeutically effective topical application of st1435 |
| 04/16/1997 | EP0536282B1 Meducament for treating prostatic adenocarcinoma |
| 04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
| 04/08/1997 | US5618806 Steroid 5alpha-reductase inhibitor; useful for treating benign prostatic hypertrophy, baldness, acne, vulguris, seborrhea, female hirsutism, and prostatic adenocarcinoma |
| 04/01/1997 | US5616743 16-methyl-Δ1,4 -pregnadiene-3,20-diones |
| 04/01/1997 | US5616742 Dechlorination, alkenylation |
| 03/27/1997 | WO1996040043A3 Neuroactive steroids of the androstane and pregnane series |
| 03/25/1997 | US5614514 Steroid esters |
| 03/19/1997 | EP0763054A1 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 03/12/1997 | EP0422100B1 11 beta-substituted progesterone analogs |
| 03/04/1997 | US5608093 Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, and pharmaceuticals containing these compounds |
| 02/11/1997 | CA1338906C 11 beta-substituted progesterone analogs |
| 02/05/1997 | EP0756601A1 Compositions and methods for cell transformation |
| 01/29/1997 | CN1141301A 9-alpha-hydroxyl-17-methylene steroids, process for their prepn. and their use in prepn. of corticosteroids |
| 01/22/1997 | EP0754456A2 Topical application of ST1435 as a contraceptive agent |
| 01/21/1997 | US5596110 Process for the preparation of 3 β, 14 β-dihydroxyethianaldehyde |
| 01/21/1997 | US5596108 Intermediates for betamethasone |
| 01/15/1997 | EP0752860A1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 01/15/1997 | CN1140178A Use of new steroid compound for preparing medicaments |
| 01/15/1997 | CN1140059A Process for preparing pharmaceutical composition contg. new steroid compounds |
| 01/07/1997 | US5591733 Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/02/1997 | EP0680328B1 Topical ketoconazole compositions |
| 12/19/1996 | WO1996040727A1 Novel nor-pregnanes for inducing hypothalamic effects |
| 12/19/1996 | WO1996040043A2 Neuroactive steroids of the androstane and pregnane series |
| 12/19/1996 | CA2223996A1 Neuroactive steroids of the androstane and pregnane series |
| 12/17/1996 | US5585482 Preparation of 11-keto steroids |
| 11/07/1996 | WO1996034858A1 Nicotinic acid esters and pharmaceutical compositions containing them |
| 11/07/1996 | WO1996034855A1 Fatty acid esters as bioactive compounds |
| 11/07/1996 | WO1996034846A1 1,3-propane diol derivatives as bioactive compounds |
| 11/06/1996 | EP0740650A1 Codrugs as a method of controlled drug delivery |
| 10/16/1996 | CN1133296A 11 beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 10/16/1996 | CN1033032C Prepn. of 19-substituted progesterone derivatives |
| 10/15/1996 | US5565588 Introducing substituents on starting compound containing 9-alpha-hydroxy group |
| 09/17/1996 | US5556964 Acetylization with butanal in acetonitrile in the presence of p-toluenesulfonic acid catalyst |
| 09/17/1996 | US5556962 Chemical intermediates with sulfide protective groups for ketones |
| 07/30/1996 | US5540919 Method for enhancement of production of lymphokines and applications thereof |
| 07/25/1996 | WO1996022303A1 Therapeutic compound - fatty acid conjugates |
| 07/25/1996 | CA2210500A1 Therapeutic compound - fatty acid conjugates |
| 07/17/1996 | CN1126727A 11,21-bisphenyl-19-norpregnane derivatives |
| 07/03/1996 | CN1032211C Process for preparing 9-alpha-hydroxy-17-methylene steroids |
| 06/12/1996 | CN1124250A 17-deoxycorticosteroid-21-|O¨-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 05/30/1996 | WO1996016076A1 Androstane and pregnane series for allosteric modulation of gaba receptor |
| 05/30/1996 | CA2205919A1 Androstane and pregnane series for allosteric modulation of gaba receptor |
| 05/29/1996 | EP0713393A1 Estrogenic compounds as anti-mitotic agents |
| 05/22/1996 | EP0589034A4 Method for making 3-g(a)-hydroxy,3-g(b)-substituted-pregnanes |
| 05/21/1996 | US5519027 D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 04/24/1996 | EP0708111A1 17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them |
| 04/16/1996 | US5508452 Preparation of 16α-methyl steroids |
| 04/09/1996 | US5506354 Antiulcer, antiturmor, antiarthritic, antiatherosclerosis, antiallergic, antiasthma agents |
| 04/09/1996 | US5506220 Derivatives of 17-alpha-hydroxy-3,20-dioxo-19-norpregna-4-ene |
| 04/02/1996 | US5504203 Reacting tri-keto derivative with an alkyl cyanacetate, epoxidation, reduction, hofmann degradation, optional releasing of 3-ketone |
| 04/02/1996 | US5504074 Administering substituted estranes to suppress vascularization |
| 03/26/1996 | US5502222 Process for preparing delta 9,11 and 21-chloro corticosteroids |
| 03/26/1996 | US5502183 Steroid intermediates and processes for their preparation |
| 03/26/1996 | US5502182 Process for the preparation of hydrocortisone |
| 03/20/1996 | EP0702025A1 Process for the preparation of 17beta-carboxy steroids and new intermediates |
| 03/20/1996 | EP0701444A1 Methods and compositions for inducing sleep |
| 03/13/1996 | EP0495825B1 Use of antigestagens in the manufacture of medicaments |
| 03/13/1996 | CN1118352A New steroids containing in position 20 an aminosubstitued chain, preparation procass and intermediates of this process, use as medicaments and pharmaceutical compositions containing them |
| 03/13/1996 | CN1118351A New preparation process for a 16SS-methyl steroid and new intermediates |
| 03/07/1996 | CA2157550A1 Process for preparing a 17-.beta.-carboxy steroid derivative and new in termediates |
| 03/05/1996 | US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative |
| 02/14/1996 | CN1116824A Topical ketoconazole compositions |
| 02/08/1996 | WO1996003421A1 Neurologically active aminosteroids |
| 02/07/1996 | CN1116208A 9-alpha-hydroxy steroids, process for their preparation, process for the preparation of the corresponding 9(11)-dehydro derivatives and pharmaceutical preparations containing said steroids |
| 01/10/1996 | CN1114654A Novel colon- or ileum-specific steroid derivatives |
| 01/09/1996 | US5482934 Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
| 01/03/1996 | EP0690069A1 Process for the preparation of 20-oxo, 17-alpha, 21 dihydroxy steroid derivatives and new intermediates thereof |
| 12/07/1995 | WO1995032989A1 Process for preparing δ9,11 and 21-chloro corticosteroids |
| 12/06/1995 | EP0685487A1 A new method of preparation of a 16-beta-steroid and new intermediates of said preparation |
| 11/29/1995 | EP0684256A2 Improved process for the preparation of 3 beta, 14 beta-dihydroxyethialnaldehyde |
| 11/22/1995 | EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives |
| 11/15/1995 | EP0494942B1 Process for the manufacture of budesonide |
| 11/15/1995 | EP0238545B1 C20 through c26 amino steroids |
| 11/15/1995 | CN1111513A Fungicidal compositions containing bifonazole |
| 11/02/1995 | WO1995029186A1 Compositions and methods for cell transformation |
| 11/02/1995 | CA2188320A1 Compositions and methods for cell transformation |
| 10/11/1995 | EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide |
| 10/11/1995 | CN1029975C Process for preparing 9(11)-dehydro steroids |
| 10/10/1995 | USRE35053 Intermediates for amino substituted steroids |
| 10/04/1995 | EP0675134A1 New 20-amino substituted steroid compounds, a method for their production and intermediates therefor and pharmaceutical compositions containing them |
| 10/02/1995 | CA2146085A1 Steroids containing an aminosubstituted chain in position 20; process and intermediates therefor; their use as drugs and pharmaceutical compositions containing them |
| 09/27/1995 | EP0673251A1 17 substituted acyl-3-carboxy 3,5-diene steroidals as 5-alpha-reductase inhibitors |
| 09/20/1995 | CN1108661A Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 09/19/1995 | US5451690 Lambda-1,4-pregnadiene-3,20-diones |
| 09/06/1995 | EP0670163A1 Use of pentoxifylline for the manufacture of a medicament for the treatment of fibrosing or granulomatosing lung diseases |
| 09/06/1995 | EP0669932A1 17-alpha and 17-beta substituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-alpha-reductase |
| 09/06/1995 | CN1029683C Process for preparing new steroids substituted at position 10 by a radical including a double or triple bond |
| 08/29/1995 | US5446177 No increase in intraocular pressure during chronic use |